Frova and Norvasc drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Frova (frovatriptan succinate) and Norvasc (amlodipine besylate). Common drug interactions include arthralgia among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Frova and Norvasc. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Frova?

Frova has active ingredients of frovatriptan succinate. It is often used in migraine. eHealthMe is studying from 2,100 Frova users. Check the latest studies of Frova.

What is Norvasc?

Norvasc has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 136,738 Norvasc users. Check the latest studies of Norvasc.



On Jul, 27, 2026

18 people who take Frova and Norvasc together, and have interactions are studied.

Frova and Norvasc drug interactions.

What are the common drug interactions of Frova and Norvasc, by gender? *:

female:

  1. Arthralgia (joint pain)
  2. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  3. Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
  4. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  5. Pulmonary embolism (blockage of the main artery of the lung)
  6. Sinusitis (inflammation of sinus)
  7. Weight increased
  8. Neuropathy peripheral (surface nerve damage)
  9. Activities of daily living impaired
  10. Alanine aminotransferase increased

male:

  1. Chronic kidney disease
  2. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  3. Renal failure (kidney dysfunction)
  4. Renal tubular necrosis (death of kidney tubules)
  5. Secondary hyperthyroidism

What are the common drug interactions of Frova and Norvasc, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  2. Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
  3. Injury
  4. Pain
  5. Pulmonary embolism (blockage of the main artery of the lung)

30-39:

n/a

40-49:

  1. Cough
  2. Euphoric mood (excessively happy but may become angry or irritable)
  3. Increased upper airway secretion
  4. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)

50-59:

  1. Toothache (tooth pain)
  2. Tremor (trembling or shaking movements in one or more parts of your body)
  3. Upper respiratory tract infection
  4. Ventricular extrasystoles (premature cardiac contraction)
  5. Vitamin d decreased
  6. Vomiting
  7. White blood cell count increased
  8. Abdominal pain upper
  9. Activities of daily living impaired
  10. Alanine aminotransferase increased

60+:

  1. Neuropathy peripheral (surface nerve damage)
  2. Abdominal pain upper
  3. Oral infection
  4. Pain
  5. Renal failure (kidney dysfunction)
  6. Renal tubular necrosis (death of kidney tubules)
  7. Secondary hyperthyroidism
  8. Sinusitis (inflammation of sinus)
  9. Tenderness (pain or discomfort when an affected area is touched)
  10. Tooth disorder (tooth disease)

What are the existing conditions these people have? *

  1. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 3 people, 16.67%
  2. Birth Control: 2 people, 11.11%
  3. Stress And Anxiety: 1 person, 5.56%
  4. Headache (pain in head): 1 person, 5.56%
  5. Bipolar Disorder (mood disorder): 1 person, 5.56%
  6. Breast Cancer: 1 person, 5.56%
  7. Depression: 1 person, 5.56%
  8. Essential Hypertension (primary hypertension): 1 person, 5.56%
  9. Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 5.56%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Frova and Norvasc?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Frova and Norvasc:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Frova:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Norvasc:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Frova and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Norvasc and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on frovatriptan succinate and amlodipine besylate (the active ingredients of Frova and Norvasc, respectively), and Frova and Norvasc (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: